Target intelligence / Profile preview

1,3-β-Glucan synthase enzyme complex (GS)

Target
GS
Molecular classification
Enzyme, Glycosyltransferase, Membrane protein complex, Other: Cell wall biosynthetic enzyme
01

Overview

The 1,3-β-glucan synthase enzyme complex is a multi-protein, membrane-embedded enzyme found in fungi, responsible for the biosynthesis of β-1,3-glucan, the principal structural polysaccharide of the fungal cell wall. Its core consists of a catalytic glycosyltransferase subunit (FKS1, FKS2, or FKS3 in yeast) that uses UDP-glucose as substrate to elongate β-1,3-glucan chains, and a regulatory subunit (Rho1, a small GTPase). This enzyme is essential for fungal viability, as it provides cell wall rigidity and resistance to environmental stresses. Because humans do not have β-1,3-glucan in their cells, this enzyme is a prime target for antifungal drugs—most notably, echinocandin-class antifungals and ibrexafungerp—which inhibit the synthase and disrupt fungal cell wall integrity, leading to cell lysis. The complex’s catalytic mechanisms, structure (recently elucidated by cryo-EM), and the emergence of resistance due to FKS1 mutations are intensively studied in antifungal research.

Other names
1,3-β-glucan synthaseβ-glucan synthaseFKS complexFks1/2/3 complexβ-1,3-glucan synthase complexGS complexFungal glucan synthaseβ-d-glucan synthaseFks1-Rho1 complex
02

Mechanism of action

Inhibition of β-1,3-glucan synthesis: Echinocandins and ibrexafungerp bind GS, preventing β-1,3-glucan formation and resulting in defective fungal cell walls and cell death

03

Biological functions

Fungal cell wall biosynthesisFormation of β-1,3-glucan polysaccharide chainsMaintaining cell wall integrityCell shape and mechanical stability
04

Disease associations

InfectionOther: Essential for fungal viability
05

Safety considerations

Potential for antifungal resistanceOff-target toxicityEmergence of drug-resistant fungal infections
06

Interacting drugs

Echinocandins

1 more in the full profile.

07

Biomarkers

β-1,3-glucan levels in bloodGenetic mutations in FKS1/FKS2

Beyond the preview

Go deeper on 1,3-β-Glucan synthase enzyme complex (GS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1,3-β-Glucan synthase enzyme complex (GS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call